Inhaler
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
FIG. 1 is front elevational view of an inhaler showing our new design;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a top plan view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a side elevational view thereof;
FIG. 6 is a side elevational view thereof, opposite that shown in FIG. 5.
FIG. 7 is a perspective view thereof;
FIG. 8 is a front elevational thereof, with the cover shown in retracted position;
FIG. 9 is a front elevational view of a second embodiment of an inhaler showing our new design;
FIG. 10 is a rear elevational view thereof;
FIG. 11 is a top plan view thereof;
FIG. 12 is a bottom plan view thereof;
FIG. 13 is a side elevational view thereof;
FIG. 14 is a side elevational view thereof, opposite that shown in FIG. 13.
FIG. 15 is a perspective view thereof; and,
FIG. 16 is a front elevational thereof, with the cover shown in retracted position.
Claims
The ornamental design for an inhaler, as shown and described.
D437931 | February 20, 2001 | Anderson |
D450117 | November 6, 2001 | Braithwaite et al. |
D478983 | August 26, 2003 | Whitehall et al. |
6792945 | September 21, 2004 | Davies et al. |
20040134488 | July 15, 2004 | Davies |
20050172964 | August 11, 2005 | Anderson et al. |
Type: Grant
Filed: Jun 3, 2005
Date of Patent: Mar 28, 2006
Assignee: Glaxo Group Limited (Greenford)
Inventors: Gregor John McLennan Anderson (Ware), Philip William Farr (Ware), Andrew Michael Kelly (Ware)
Primary Examiner: Ian Simmons
Attorney: James P. Riek
Application Number: 29/231,387